What is the global market size of Alopecia Market?

Alopecia Market size was valued at USD 2.97 billion in 2021 and is poised to grow from USD 3.21 billion in 2022 to USD 4.91 billion by 2030, growing at a CAGR of 8% in the forecast period (2023-2030).

Alopecia Market Size, Share, Growth Analysis, By Disease type(Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment(Pharmaceuticals, Devices), By Gender(Male, Female), By Sales Channel(Prescriptions, OTC), By End Use(Homecare setting, dermatology clinics), By Region - Industry Forecast 2024-2031

Report ID: SQSG35I2021 | Region: Global | Published Date: April, 2024
Pages: 165 | Tables: 141 | Figures: 78

Alopecia Market Competitive Landscape

Alopecia Market Top Player’s Company Profiles

Johnson & Johnson
Merck & Co.
Pfizer Inc.
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Aclaris Therapeutics, Inc.
Concert Pharmaceuticals, Inc.
HCell Inc.
Follica, Inc.
Histogen Inc.
Allergan plc
Bayer AG
Kythera Biopharmaceuticals, Inc.
Polichem S.A.
Takeda Pharmaceutical Company Limited
Almirall, S.A.
Perrigo Company plc
Vegalab, Inc.

Alopecia Market Recent Development

In August 2021, Ritlecitinib's phase 2b/3 trial for alopecia areata's positive top-line results had already been made public by Pfizer. The Janus kinase 3 (JAK3) and members of the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family are the first targets of a new class of covalent kinase inhibitors, which include rociletinib. In laboratory tests, rociletinib was discovered to inhibit the activity of immune cells and signalling molecules that are suspected to be involved in alopecia areata patients' hair loss.

Alopecia Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

US Alopecia Market is poised to grow at a sustainable CAGR for the next forecast year.

Due to rising knowledge of alopecia treatments and increased acceptance of alopecia treatment products, Asia-Pacific offers lucrative prospects for key players operating in the alopecia treatment market. Additionally, the expansion of hospitals with cutting-edge medical facilities, and improvement in healthcare infrastructure, progress in the R&D sector, an increase in healthcare reforms, and technical developments in the healthcare industry all contribute to the market's expansion. 'Johnson & Johnson', 'Merck & Co.', 'Pfizer Inc.', 'Cipla Limited', 'Dr. Reddy's Laboratories Ltd.', 'Sun Pharmaceutical Industries Ltd.', 'GlaxoSmithKline plc', 'Aclaris Therapeutics, Inc.', 'Concert Pharmaceuticals, Inc.', 'HCell Inc.', 'Follica, Inc.', 'Histogen Inc.', 'Allergan plc', 'Bayer AG', 'Kythera Biopharmaceuticals, Inc.', 'Polichem S.A.', 'Takeda Pharmaceutical Company Limited', 'Almirall, S.A.', 'Perrigo Company plc', 'Vegalab, Inc.'

The market for alopecia areata is expected to rise as hair loss becomes more common. According to the American Academy of Dermatology Association (AAD), around 30 million women and 50 million men in the US were estimated to have alopecia in 2021. Around 60% of people experience hair thinning, with pattern hair loss being the most prevalent kind of hair loss in both men and women, according to the Journal of Clinical and Diagnostic Research (JCDR). Additionally, regardless of gender, 2% of the general population is susceptible to developing alopecia areata in their lifetime

Alopecia can be treated with a variety of medications and surgical procedures, including hair transplantation, scalp reduction surgery, and others. The alopecia treatment market is predicted to grow significantly over the forecast period due to factors including an increase in the incidence and prevalence of chronic diseases like arthritis, Polycystic Ovary Syndrome (PCOS), cancer, and others; a change in lifestyle and an increase in stress; an increase in the population of elderly people; hormonal imbalances and unhealthy diets; and an increase in demand for alopecia treatment drugs. Additionally, during the projected period, there is expected to be attractive market expansion prospects due to the growing areas' sizable market potential.

In 2021, North America dominated the market and had the highest revenue share (36.3%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Alopecia Market Competitive Landscape

Alopecia Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Alopecia Market?

Who are the key vendors in the Alopecia Market?

What is the key driver of Alopecia Market?

What is the key market trend for Alopecia Market?

Which region accounted for the largest share in Alopecia Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300